Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 993 | 945 | 1151 | 968 | 1152 | 1398 |
Fund Return | -0.68% | -5.54% | 15.13% | -1.07% | 2.87% | 3.41% |
Place in category | 150 | 116 | 126 | 96 | 77 | 43 |
% in Category | 71 | 67 | 61 | 48 | 57 | 48 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU1313519925 | 6.65B | 0.61 | 0.70 | - | ||
LU1300848345 | 6.65B | 0.85 | 1.00 | - | ||
LU1520716801 | 4.09B | 5.79 | 2.11 | - | ||
LU1323611266 | 4.09B | 3.95 | -0.16 | - | ||
UBS Lux Equity Fund China Opportuni | 2.89B | 9.57 | -10.68 | 4.90 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU0133359157 | 1.39B | 9.50 | 3.89 | 5.82 | ||
Equities L Biotechnology Class I US | 1.39B | 10.11 | 4.23 | 6.67 | ||
Equities L Biotechnology Class R US | 1.39B | 10.64 | 5.19 | 7.15 | ||
Candriam Equities Biotech C USD Cap | 1.39B | 9.83 | 4.32 | 6.29 | ||
Pictet Biotech R USD | 1.35B | 6.51 | -0.98 | 3.00 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Vertex | US92532F1003 | 10.09 | 408.18 | +0.72% | |
Alnylam | US02043Q1076 | 7.33 | 243.25 | +0.41% | |
Neurocrine | US64125C1099 | 5.12 | 136.53 | -0.34% | |
Moderna | US60770K1079 | 4.90 | 40.27 | +1.72% | |
Amgen | US0311621009 | 4.85 | 264.49 | +0.19% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Sell |
Technical Indicators | Strong Sell | Strong Sell | Neutral |
Summary | Strong Sell | Strong Sell | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review